Analyst Price Target is $7.85
▲ +8.28% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for LifeStance Health Group in the last 3 months. The average price target is $7.85, with a high forecast of $8.00 and a low forecast of $7.25. The average price target represents a 8.28% upside from the last price of $7.25.
Current Consensus is
The current consensus among 5 contributing investment analysts is to buy stock in LifeStance Health Group. This rating has held steady since October 2022, when it changed from a Hold consensus rating.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.